OmniAb, Inc. (OABI)
1.71
+0.01
(+0.59%)
USD |
NASDAQ |
Feb 23, 16:00
1.725
+0.02
(+0.88%)
After-Hours: 19:59
OmniAb Total Assets (Quarterly) : 309.69M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GT Biopharma, Inc. | 4.321M |
| Foghorn Therapeutics, Inc. | 204.96M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Erasca, Inc. | 420.40M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.25M |
| Shareholders Equity (Quarterly) | 277.44M |
| Debt to Equity Ratio | 0.0759 |
| Current Ratio | 4.997 |
| Net Debt Paydown Yield | 0.28% |